Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Opportunities and Challenges in Implementation of Multiparameter Single Cell Analysis Platforms for Clinical Translation.

Keating SM, Taylor DL, Plant AL, Litwack ED, Kuhn P, Greenspan EJ, Hartshorn CM, Sigman CC, Kelloff GJ, Chang DD, Friberg G, Lee JSH, Kuida K.

Clin Transl Sci. 2018 May;11(3):267-276. doi: 10.1111/cts.12536. Epub 2018 Mar 2. Review.

2.

Pharmacogenetic Decision Support Tools: A New Paradigm for Late-Life Depression?

Abbott R, Chang DD, Eyre HA, Bousman CA, Merrill DA, Lavretsky H.

Am J Geriatr Psychiatry. 2018 Feb;26(2):125-133. doi: 10.1016/j.jagp.2017.05.012. Epub 2017 May 25. Review.

PMID:
29429869
3.

Effect of Serum Vitamin D Levels on Cellular Immunity and Antiviral Effects in Chronic Hepatitis B Patients.

He LJ, Zhang HP, Li HJ, Wang J, Chang DD.

Clin Lab. 2016 Oct 1;62(10):1933-1939. doi: 10.7754/Clin.Lab.2016.160210.

4.

Structural mechanism of ligand activation in human calcium-sensing receptor.

Geng Y, Mosyak L, Kurinov I, Zuo H, Sturchler E, Cheng TC, Subramanyam P, Brown AP, Brennan SC, Mun HC, Bush M, Chen Y, Nguyen TX, Cao B, Chang DD, Quick M, Conigrave AD, Colecraft HM, McDonald P, Fan QR.

Elife. 2016 Jul 19;5. pii: e13662. doi: 10.7554/eLife.13662.

5.

Similar molecular determinants on Rem mediate two distinct modes of inhibition of CaV1.2 channels.

Puckerin AA, Chang DD, Subramanyam P, Colecraft HM.

Channels (Austin). 2016 Sep 2;10(5):379-394. Epub 2016 Apr 26.

6.

hERG 1a LQT2 C-terminus truncation mutants display hERG 1b-dependent dominant negative mechanisms.

Puckerin A, Aromolaran KA, Chang DD, Zukin RS, Colecraft HM, Boutjdir M, Aromolaran AS.

Heart Rhythm. 2016 May;13(5):1121-30. doi: 10.1016/j.hrthm.2016.01.012. Epub 2016 Jan 13.

PMID:
26775140
7.
8.

LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.

Aromolaran AS, Subramanyam P, Chang DD, Kobertz WR, Colecraft HM.

Cardiovasc Res. 2014 Dec 1;104(3):501-11. doi: 10.1093/cvr/cvu231. Epub 2014 Oct 24.

9.

Manipulating L-type calcium channels in cardiomyocytes using split-intein protein transsplicing.

Subramanyam P, Chang DD, Fang K, Xie W, Marks AR, Colecraft HM.

Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15461-6. doi: 10.1073/pnas.1308161110. Epub 2013 Sep 3.

10.

Metabolites from endophytic fungus A12 of Dracaena cambodiana.

Chang DD, Zuo WJ, Mei WL, Dai HF.

J Asian Nat Prod Res. 2012;14(6):577-80. doi: 10.1080/10286020.2012.681047. Epub 2012 May 9.

PMID:
22568775
11.

Genetic polymorphisms in metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine.

Kim D, Lee YJ, Ryu HY, Lee JH, Kim HK, Kim E, Moon JD, Chang DD, Yoon HS.

J Appl Toxicol. 2013 Jan;33(1):63-70. doi: 10.1002/jat.1712. Epub 2011 Dec 1.

PMID:
22131055
12.

Neutralizing monoclonal antibody to periostin inhibits ovarian tumor growth and metastasis.

Zhu M, Saxton RE, Ramos L, Chang DD, Karlan BY, Gasson JC, Slamon DJ.

Mol Cancer Ther. 2011 Aug;10(8):1500-8. doi: 10.1158/1535-7163.MCT-11-0046. Epub 2011 Jun 13.

13.

[Clinical application and value of 3 Tesla contrast enhanced whole-heart coronary magnetic resonance angiography].

Cao ZB, Kong XQ, Chang DD, Liu DX.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Apr;39(4):329-33. doi: 10.3760/cma.j.issn.0253-3758.2011.04.010. Chinese.

PMID:
21624309
14.

Propulsion of African trypanosomes is driven by bihelical waves with alternating chirality separated by kinks.

Rodríguez JA, Lopez MA, Thayer MC, Zhao Y, Oberholzer M, Chang DD, Kisalu NK, Penichet ML, Helguera G, Bruinsma R, Hill KL, Miao J.

Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19322-7. doi: 10.1073/pnas.0907001106. Epub 2009 Oct 30.

15.

Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data.

Weiss ES, Chang DD, Joyce DL, Nwakanma LU, Yuh DD.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):503-11, 511.e1-3. doi: 10.1016/j.jtcvs.2007.10.042. Epub 2008 Feb 21.

16.

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.

Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, Juan T, Sikorski R, Suggs S, Radinsky R, Patterson SD, Chang DD.

J Clin Oncol. 2008 Apr 1;26(10):1626-34. doi: 10.1200/JCO.2007.14.7116. Epub 2008 Mar 3.

17.

Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors.

Rosen LS, Kurzrock R, Mulay M, Van Vugt A, Purdom M, Ng C, Silverman J, Koutsoukos A, Sun YN, Bass MB, Xu RY, Polverino A, Wiezorek JS, Chang DD, Benjamin R, Herbst RS.

J Clin Oncol. 2007 Jun 10;25(17):2369-76.

PMID:
17557949
19.

EPLIN regulates actin dynamics by cross-linking and stabilizing filaments.

Maul RS, Song Y, Amann KJ, Gerbin SC, Pollard TD, Chang DD.

J Cell Biol. 2003 Feb 3;160(3):399-407.

20.

Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.

Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD.

Cancer Res. 2002 Sep 15;62(18):5358-64.

21.

Gene expression in epithelial ovarian carcinoma.

Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J, Chang DD.

Oncogene. 2002 Sep 12;21(41):6289-98.

22.

ROCK-II-induced membrane blebbing and chromatin condensation require actin cytoskeleton.

Song Y, Hoang BQ, Chang DD.

Exp Cell Res. 2002 Aug 1;278(1):45-52.

PMID:
12126956
24.

Molecular basis for interaction between Icap1 alpha PTB domain and beta 1 integrin.

Chang DD, Hoang BQ, Liu J, Springer TA.

J Biol Chem. 2002 Mar 8;277(10):8140-5. Epub 2001 Dec 7.

25.
26.
27.

Differential gene expression between normal and tumor-derived ovarian epithelial cells.

Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC, Chang DD.

Cancer Res. 2000 Dec 1;60(23):6744-9.

28.

Overexpression of wild-type RhoA produces growth arrest by disrupting actin cytoskeleton and microtubules.

Song Y, Wong C, Chang DD.

J Cell Biochem. 2000 Oct 20;80(2):229-40.

PMID:
11074594
29.
30.

EPLIN, epithelial protein lost in neoplasm.

Maul RS, Chang DD.

Oncogene. 1999 Dec 16;18(54):7838-41.

31.

Inhibition of Stat1-mediated gene activation by PIAS1.

Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K.

Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10626-31.

32.

Characterization of transformation related genes in oral cancer cells.

Chang DD, Park NH, Denny CT, Nelson SF, Pe M.

Oncogene. 1998 Apr 16;16(15):1921-30.

33.

Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit.

Liliental J, Chang DD.

J Biol Chem. 1998 Jan 23;273(4):2379-83.

35.

Exon amplification: a strategy to isolate mammalian genes based on RNA splicing.

Buckler AJ, Chang DD, Graw SL, Brook JD, Haber DA, Sharp PA, Housman DE.

Proc Natl Acad Sci U S A. 1991 May 1;88(9):4005-9.

36.
37.

Messenger RNA transport and HIV rev regulation.

Chang DD, Sharp PA.

Science. 1990 Aug 10;249(4969):614-5. Review. No abstract available.

PMID:
2143313
38.

The gene for the RNA component of the mitochondrial RNA-processing endoribonuclease is located on human chromosome 9p and on mouse chromosome 4.

Hsieh CL, Donlon TA, Darras BT, Chang DD, Topper JN, Clayton DA, Francke U.

Genomics. 1990 Mar;6(3):540-4.

PMID:
2328993
39.

Regulation by HIV Rev depends upon recognition of splice sites.

Chang DD, Sharp PA.

Cell. 1989 Dec 1;59(5):789-95.

PMID:
2686839
41.

Roles for a promoter and RNA processing in the synthesis of mitochondrial displacement-loop strands.

Chang DD, Fisher RP, Clayton DA.

Biochim Biophys Acta. 1987 Jul 14;909(2):85-91. No abstract available.

PMID:
3593731
42.

A mammalian mitochondrial RNA processing activity contains nucleus-encoded RNA.

Chang DD, Clayton DA.

Science. 1987 Mar 6;235(4793):1178-84.

PMID:
2434997
43.
47.
48.
49.
50.

Priming of human mitochondrial DNA replication occurs at the light-strand promoter.

Chang DD, Clayton DA.

Proc Natl Acad Sci U S A. 1985 Jan;82(2):351-5.

Supplemental Content

Loading ...
Support Center